Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4bu9 | 08C | Tankyrase-2 | 2.4.2.30 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4bu9 | 08C | Tankyrase-2 | 2.4.2.30 | 1.000 | |
4buu | F38 | Tankyrase-2 | 2.4.2.30 | 0.843 | |
4l0s | 1UZ | Tankyrase-2 | 2.4.2.30 | 0.832 | |
4but | 31F | Tankyrase-2 | 2.4.2.30 | 0.791 | |
4bui | W2E | Tankyrase-2 | 2.4.2.30 | 0.705 | |
4hlk | 431 | Tankyrase-2 | 2.4.2.30 | 0.699 | |
3kr8 | XAV | Tankyrase-2 | 2.4.2.30 | 0.603 | |
4bud | 29F | Tankyrase-2 | 2.4.2.30 | 0.593 | |
4buf | F36 | Tankyrase-2 | 2.4.2.30 | 0.582 | |
4l10 | A63 | Tankyrase-2 | 2.4.2.30 | 0.578 | |
4kzu | A73 | Tankyrase-2 | 2.4.2.30 | 0.576 | |
4j22 | AJ7 | Tankyrase-2 | 2.4.2.30 | 0.567 | |
4hkn | LU2 | Tankyrase-2 | 2.4.2.30 | 0.565 | |
4l31 | F08 | Tankyrase-2 | 2.4.2.30 | 0.557 | |
4hkk | AGI | Tankyrase-2 | 2.4.2.30 | 0.525 | |
4l33 | F70 | Tankyrase-2 | 2.4.2.30 | 0.505 | |
4l34 | 1VG | Tankyrase-2 | 2.4.2.30 | 0.499 | |
4l0t | 1V0 | Tankyrase-2 | 2.4.2.30 | 0.497 | |
4hlg | 20B | Tankyrase-2 | 2.4.2.30 | 0.483 | |
5aku | 29F | Tankyrase-2 | 2.4.2.30 | 0.460 | |
4l2f | 1V3 | Tankyrase-2 | 2.4.2.30 | 0.450 | |
4kzl | 20D | Tankyrase-2 | 2.4.2.30 | 0.449 | |
4l0i | 1UW | Tankyrase-2 | 2.4.2.30 | 0.449 | |
4l0v | 1V1 | Tankyrase-2 | 2.4.2.30 | 0.443 |